Matthews Asia Growth Fund

Top 10 Holdings as of 2/28/2019

Security Sector Country % Net Assets
Wuxi Biologics Cayman, Inc. Health Care China/Hong Kong 4.3
Shenzhou International Group Holdings, Ltd. Consumer Discretionary China/Hong Kong 3.6
PT Bank Rakyat Indonesia Persero Financials Indonesia 3.3
HDFC Bank, Ltd. Financials India 3.1
CSL, Ltd. Health Care Australia 3.0
Terumo Corp. Health Care Japan 2.9
Baozun, Inc. Consumer Discretionary China/Hong Kong 2.8
M3, Inc. Health Care Japan 2.8
Square Pharmaceuticals, Ltd. Health Care Bangladesh 2.6
SoftBank Group Corp. Communication Services Japan 2.6
Total 31.0
Top 10 holdings may combine more than one security from the same issuer and related depositary receipts.
Source: BNY Mellon Investment Servicing (US) Inc.
The Matthews Asia Funds Portfolio Holding Disclosure Policy (“Policy”) has been updated to allow certain Fund portfolio holdings to be disclosed on a monthly basis. Please contact us if you would like to receive monthly holdings in accordance with the Policy for this Fund.

Portfolio Breakdown (%) as of 12/31/2018

  Fund MSCI All Country Asia Pacific Index Difference
Health Care 30.0 5.9 24.1
Consumer Discretionary 25.2 14.0 11.2
Financials 14.4 20.9 -6.5
Consumer Staples 10.7 6.7 4.0
Communication Services 5.6 9.6 -4.0
Industrials 5.3 12.2 -6.9
Information Technology 3.0 12.2 -9.2
Energy 1.3 3.4 -2.1
Materials 1.0 6.6 -5.6
Real Estate 0.0 5.6 -5.6
Utilities 0.0 2.8 -2.8
Cash and Other Assets, Less Liabilities 3.5 0.0 3.5
  Fund MSCI All Country Asia Pacific Index Difference
Japan 36.8 37.7 -0.9
China/Hong Kong 25.1 23.9 1.2
Indonesia 11.1 1.4 9.7
India 5.5 5.5 0.0
Australia 4.7 10.6 -5.9
Bangladesh 4.3 0.0 4.3
Sri Lanka 2.9 0.0 2.9
Philippines 1.7 0.7 1.0
Vietnam 1.7 0.0 1.7
Thailand 1.3 1.4 -0.1
Taiwan 1.2 6.7 -5.5
South Korea 0.0 8.1 -8.1
Singapore 0.0 2.1 -2.1
Malaysia 0.0 1.4 -1.4
New Zealand 0.0 0.4 -0.4
Pakistan 0.0 0.0 0.0
Cash and Other Assets, Less Liabilities 3.5 0.0 3.5
Not all countries are included in the benchmark index.
  Fund MSCI All Country Asia Pacific Index Difference
Mega Cap (over $25B) 28.3 49.4 -21.1
Large Cap ($10B-$25B) 18.2 24.6 -6.4
Mid Cap ($3B-$10B) 24.2 23.3 0.9
Small Cap (under $3B) 25.8 2.7 23.1
Cash and Other Assets, Less Liabilities 3.5 0.0 3.5
Equity market cap of issuer.
Source: FactSet Research Systems.

Portfolio Characteristics as of 12/31/2018

Number of Securities1


Weighted Average
Market Cap

$27.0 billion

P/E using FY1 estimates


P/E using FY2 estimates


1Source: BNY Mellon Investment Servicing (US) Inc.
Source: FactSet Research Systems unless otherwise noted. Sector data (excluding Government Bonds) based on MSCI’s revised Global Industry Classification Standards. For more details, visit

Additional performance, attribution, liquidity, value at risk (VaR), security classification and holdings information is available on request for certain time periods.

Percentage values in data are rounded to the nearest tenth of one percent, so the values may not sum to 100% due to rounding.  Percentage values may be derived from different data sources and may not be consistent with other Fund literature. 

The P/E Ratio is the share price of a stock as of the report date, divided by the forecasted earnings per share for a 12-month period (FY1) and 24 month period (FY2). For the Fund, this is the weighted harmonic average estimated P/E ratio of all the underlying stocks in the Fund, excluding negative earners. There is no guarantee that the composition of the Fund will remain unchanged, or that forecasted earnings of a stock will be realized. Information provided is for illustrative purposes only.

Index Definitions

The information contained in this document does not, in any way, constitute investment advice. It should not be assumed that any investment will be profitable or will equal the performance of the portfolios or any securities or any sectors mentioned herein. The information does not constitute a recommendation to buy or sell any securities mentioned. Information on this document is from sources considered reliable, but no representation or warranty is made as to its completeness or accuracy.